Literature DB >> 189327

Peptide enhancement of neuromuscular function: animal and clinical studies.

F L Strand, A Cayer, E Gonzalez, H Stoboy.   

Abstract

Evidence is presented for an extra-adrenal effect of ACTH and ACTH analogs on muscle action potentials (APs), contractions and fatigue in in situ experiments. ACTH, alphaMSH, betaMSH and ACTH 4-10 increase the amplitude of APs and contractions and decrease fatigue in intact, hypophysectomized and in adrenalectomized rats, subjected to repetitive indirect stimulation (supermaximal strength, 5/sec or 10/sec for 30 min). Elevation of endogenous ACTH resulting from adrenalectomy or cold stress, or both, has the same effect as ACTH administration. ACTH peptides are most effective in depressed physiological conditions e.g. following hypophysectomy. As the effect of ACTH 4-10 is abolished after section of the motor nerve, it is inferred that this peptide may affect central motor neurons. Preliminary observations from clinical studies with ACTH 4-10 in patients with muscle disease, in whom a pathological decline in amplitude of a short series of evoked muscle APs was prevented by peptide administration, also indicate a possible action of this peptide on central nervous system neurons.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 189327     DOI: 10.1016/0091-3057(76)90349-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  ACTH (Acthar Gel) Reduces Toxic SOD1 Protein Linked to Amyotrophic Lateral Sclerosis in Transgenic Mice: A Novel Observation.

Authors:  Hasan Arrat; Thomas J Lukas; Teepu Siddique
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

2.  Pharmacodynamics and tolerability of repository corticotropin injection in healthy human subjects: A comparison with intravenous methylprednisolone.

Authors:  Ritu Lal; Stacie Bell; Rashida Challenger; Vakessa Hammock; Mary Nyberg; Dima Decker; Patrice M Becker; David Young
Journal:  J Clin Pharmacol       Date:  2015-09-10       Impact factor: 3.126

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.